NM Coordinating Committee: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 18: | Line 18: | ||
::* TC99m Biomarker Committee [page: https://qibawiki.rsna.org/index.php/TC99m_Biomarker_Committee] | ::* TC99m Biomarker Committee [page: https://qibawiki.rsna.org/index.php/TC99m_Biomarker_Committee] | ||
::* I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee] | ::* I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee] | ||
::* PET Myocardial Blood Flow [page: https://qibawiki.rsna.org/index.php/PET_Myocardial_Blood_Flow_Biomarker_Committee] | |||
==Meetings== | ==Meetings== | ||
* Zoom calls are held Quarterly. Please contact RSNA Staff for details. | * Zoom calls are held Quarterly. Please contact RSNA Staff for details. | ||
Revision as of 22:59, 17 May 2022
Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD
RSNA Staff Support: Julie Lisiecki
Scope
The NM Coordinating Committee is responsible for:
- Monitoring and coordinating the activities of NM Biomarker Committees
- QIBA Profile Dashboard (NM Page)
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the NM Biomarker Committees
- FDG-PET_Biomarker_Ctte
- PET_Amyloid_Biomarker_Ctte
- SPECT_Biomarker_Ctte
- TC99m Biomarker Committee [page: https://qibawiki.rsna.org/index.php/TC99m_Biomarker_Committee]
- I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee]
- PET Myocardial Blood Flow [page: https://qibawiki.rsna.org/index.php/PET_Myocardial_Blood_Flow_Biomarker_Committee]
Meetings
- Zoom calls are held Quarterly. Please contact RSNA Staff for details.